These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31677951)

  • 1. ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases.
    Bollaerts K; de Smedt T; McGee C; Emborg HD; Villa M; Alexandridou M; Duarte-Salles T; Gini R; Bartolini C; de Lusignan S; Tin Tin Htar M; Titievsky L; Sturkenboom M; Bauchau V
    Vaccine; 2020 Dec; 38 Suppl 2():B76-B83. PubMed ID: 31677951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example.
    Emborg HD; Kahlert J; Braeye T; Bauwens J; Bollaerts K; Danieli G; Duarte-Salles T; Glismann S; Huerta-Alvarez C; de Lusignan S; Martín-Merino E; McGee C; Correa A; Tramontan L; Weibel D; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B22-B30. PubMed ID: 31677953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.
    Bollaerts K; Ledent E; de Smedt T; Weibel D; Emborg HD; Danieli G; Duarte-Salles T; Huerta-Alvarez C; Martín-Merino E; Picelli G; Tramontan L; Sturkenboom M; Bauchau V
    Vaccine; 2020 Dec; 38 Suppl 2():B65-B75. PubMed ID: 31677947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project.
    Braeye T; Emborg HD; Llorente-García A; Huerta C; Martín-Merino E; Duarte-Salles T; Danieli G; Tramontan L; Weibel D; McGee C; Villa M; Gini R; Lehtinen M; Titievsky L; Sturkenboom M
    Vaccine; 2020 Apr; 38(16):3243-3254. PubMed ID: 32171573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.
    Weibel D; Dodd C; Mahaux O; Haguinet F; De Smedt T; Duarte-Salles T; Picelli G; Tramontan L; Danieli G; Correa A; McGee C; Martín-Merino E; Huerta-Alvarez C; Berencsi K; Emborg HD; Bollaerts K; Bauchau V; Titievsky L; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B38-B46. PubMed ID: 31677946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations.
    Sturkenboom M; Braeye T; van der Aa L; Danieli G; Dodd C; Duarte-Salles T; Emborg HD; Gheorghe M; Kahlert J; Gini R; Huerta-Alvarez C; Martín-Merino E; McGee C; de Lusignan S; Picelli G; Roberto G; Tramontan L; Villa M; Weibel D; Titievsky L
    Vaccine; 2020 Dec; 38 Suppl 2():B8-B21. PubMed ID: 32061385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination.
    Tin Tin Htar M; de Ridder M; Braeye T; Correa A; McGee C; de Lusignan S; Duarte-Salles T; Huerta-Alvarez C; Martín-Merino E; Tramontan L; Danieli G; Picelli G; van der Maas N; Berencsi K; Arnheim-Dahlström L; Heininger U; Emborg HD; Weibel D; Bollaerts K; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B31-B37. PubMed ID: 31677949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project.
    Braeye T; Bauchau V; Sturkenboom M; Emborg HD; García AL; Huerta C; Merino EM; Bollaerts K
    PLoS One; 2019; 14(9):e0222296. PubMed ID: 31532806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data.
    Dodd C; de Ridder M; Weibel D; Mahaux O; Haguinet F; de Smedt T; de Lusignan S; McGee C; Duarte-Salles T; Emborg HD; Huerta-Alvarez C; Martín-Merino E; Picelli G; Berencsi K; Danieli G; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B47-B55. PubMed ID: 32280043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project.
    Gini R; Dodd CN; Bollaerts K; Bartolini C; Roberto G; Huerta-Alvarez C; Martín-Merino E; Duarte-Salles T; Picelli G; Tramontan L; Danieli G; Correa A; McGee C; Becker BFH; Switzer C; Gandhi-Banga S; Bauwens J; van der Maas NAT; Spiteri G; Sdona E; Weibel D; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B56-B64. PubMed ID: 31677950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit-Risk Monitoring of Vaccines Using an Interactive Dashboard: A Methodological Proposal from the ADVANCE Project.
    Bollaerts K; De Smedt T; Donegan K; Titievsky L; Bauchau V
    Drug Saf; 2018 Aug; 41(8):775-786. PubMed ID: 29582392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.
    Sturkenboom M; Bahri P; Chiucchiuini A; Grove Krause T; Hahné S; Khromava A; Kokki M; Kramarz P; Kurz X; Larson HJ; de Lusignan S; Mahy P; Torcel-Pagnon L; Titievsky L; Bauchau V;
    Vaccine; 2020 Dec; 38 Suppl 2():B1-B7. PubMed ID: 31677952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project.
    Willame C; Dodd C; van der Aa L; Picelli G; Emborg HD; Kahlert J; Gini R; Huerta C; Martín-Merino E; McGee C; de Lusignan S; Roberto G; Villa M; Weibel D; Titievsky L; Sturkenboom MCJM
    Drug Saf; 2021 Mar; 44(3):383-395. PubMed ID: 33462778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval.
    Martín-Merino E; Llorente-García A; Castillo Cano B; Montero Corominas D; Huerta-Álvarez C
    Pharmaceut Med; 2019 Dec; 33(6):519-530. PubMed ID: 31933243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inequalities in vaccination coverage and differences in follow-up procedures for asylum-seeking children arriving in Wales, UK.
    Perry M; Townson M; Cottrell S; Fagan L; Edwards J; Saunders J; O'Hare R; Richardson G
    Eur J Pediatr; 2020 Jan; 179(1):171-175. PubMed ID: 31701239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination Coverage Among Children Aged 2 Years - U.S. Affiliated Pacific Islands, April-October, 2016.
    Tippins A; Murthy N; Meghani M; Solsman A; Apaisam C; Basilius M; Eckert M; Judicpa P; Masunu Y; Pistotnik K; Pedro D; Sasamoto J; Underwood JM
    MMWR Morb Mortal Wkly Rep; 2018 May; 67(20):579-584. PubMed ID: 29795077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.
    Stein-Zamir C; Israeli A
    Hum Vaccin Immunother; 2017 Sep; 13(9):2102-2110. PubMed ID: 28696824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced passive surveillance of influenza vaccination in England, 2016-2017- an observational study using an adverse events reporting card.
    de Lusignan S; Ferreira F; Damaso S; Byford R; Pathirannehelage S; Yeakey A; Yonova I; Schuind A; Dos Santos G
    Hum Vaccin Immunother; 2019; 15(5):1048-1059. PubMed ID: 30648923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of vaccination coverage of adolescents aged 16-18 years with an innovative electronic immunization record system.
    Gault G; Fischer A; Nicand E; Burelle F; Burbaud A; Koeck JL
    Med Mal Infect; 2019 Feb; 49(1):38-46. PubMed ID: 30527973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.